Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 23, 2012
Old drugs, new purpose: retooling existing drugs for optimized treatment of resistant tuberculosisKelly E Dooley, Carole D Mitnick, Mary Ann DeGroote, et al.
BMC Pregnancy and Childbirth|May 13, 2022
Multi-site observational maternal and infant COVID-19 vaccine study (MOMI-vax): a study protocolFlor M Munoz, Richard H Beigi, Christine M Posavad, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 27, 2015
A Blueprint to Address Research Gaps in the Development of Biomarkers for Pediatric TuberculosisMark Patrick Nicol, Devasena Gnanashanmugam, Renee Browning, et al.
American Journal of Respiratory and Critical Care Medicine|July 9, 2011
CDC/NIH Workshop. Tuberculosis biomarker and surrogate endpoint research roadmapPayam Nahid, Jussi Saukkonen, William R Mac Kenzie, et al.
Plos Neglected Tropical Diseases|May 31, 2014
Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical studyBecky L Rivoire, Nathan A Groathouse, Stephen TerLouw, et al.
Vaccine|March 19, 2013
Template protocol for clinical trials investigating vaccines--focus on safety elementsJan Bonhoeffer, Egeruan B Imoukhuede, Grace Aldrovandi, et al.
Vaccine|February 25, 2026
The safety, reactogenicity, and immunogenicity of the self-amplifying mRNA COVID-19 vaccine GRT-R910 as a booster in healthy adultsJennifer A Whitaker, Paulina A Rebolledo, Getahun Abate, et al.
The Lancet. Infectious Diseases|May 11, 2015
Towards early inclusion of children in tuberculosis drugs trials: a consensus statementSharon Nachman, Amina Ahmed, Farhana Amanullah, et al.
Pageof 2